LAUSR

Duration of Adjuvant Chemotherapy in Colon Cancer: Current Standards and New Updates

Sign Up to like & get
recommendations!
1 Published in 2019 at "Current Colorectal Cancer Reports"

DOI: 10.1007/s11888-019-00438-y

Abstract: Purpose of ReviewAdjuvant therapy for 6 months is the standard of care for stage III colon cancer. The use of oxaliplatin-based therapy over fluoropyrimidine alone increases toxicity, including dose-dependent peripheral neuropathy. Evaluation of a shorter duration… read more here.

Keywords: adjuvant chemotherapy; duration; duration adjuvant; colon cancer ... See more keywords

Duration of adjuvant immunotherapy—biologic, clinical and economic considerations

Sign Up to like & get
recommendations!
0 Published in 2018 at "Medical Oncology"

DOI: 10.1007/s12032-018-1218-0

Abstract: The financial impact of an extensive duration of adjuvant immunotherapy is severe. The clinical and biological rationale for this extensive duration is unclear. This study aims to understand the biologic and clinical rationale for the… read more here.

Keywords: treatment; adjuvant immunotherapy; duration; duration adjuvant ... See more keywords